Literature DB >> 15683140

Symptoms of attention-deficit/hyperactivity disorder in adults with restless legs syndrome.

Mary L Wagner1, Arthur S Walters, Barbara C Fisher.   

Abstract

OBJECTIVE: To determine the occurrence of symptoms of attention-deficit/hyperactivity disorder (ADHD) in adults with restless legs syndrome (RLS), normal controls, and controls with insomnia.
SETTING: University-based hospital.
METHODS: The occurrence and severity of current ADHD symptoms were determined in a prospective study of sequential adult patients with RLS (n = 62) or insomnia (n = 32) and adult controls (n = 77) using Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV) ADHD criteria, the Brown Attention-Deficit Disorder (ADD) Scale for adults, and a structured psychological interview. RLS severity was assessed using the International RLS Study Group Rating Scale (IRLS).
RESULTS: Only 1 experimental subject had previously been diagnosed with ADHD. More RLS patients (26%) than insomnia patients (6%) or controls (5%) had ADHD symptoms using age-adjusted total DSM-IV ADHD scores (P < .01). The mean Brown ADD score was greater in RLS patients (37 +/- 28) than in patients with insomnia (24 +/- 18) or controls (21 +/- 18) (P < .01). The RLS symptom severity (0-40 scale) was greater in RLS patients with ADD symptoms (26 +/- 9) than in those without ADD (21 +/- 10) (P < .04). Of the subjects with a Brown ADD score > 40, all reported ADD symptoms in 2 settings, and the majority had had ADHD symptoms since childhood. For subjects with a Brown ADD score > 40, there were no differences between the RLS, insomnia control, and normal control groups in quality of life or the level of anxiety or depression.
CONCLUSIONS: ADHD symptoms are more common in RLS patients than in patients with insomnia or controls. RLS leg discomfort or poor quality of sleep may theoretically lead to hyperactivity and lack of concentration. Alternatively, RLS and ADHD may be part of a single symptom complex, and dopaminergic deficiency may play a role in both disorders.

Entities:  

Mesh:

Year:  2004        PMID: 15683140     DOI: 10.1093/sleep/27.8.1499

Source DB:  PubMed          Journal:  Sleep        ISSN: 0161-8105            Impact factor:   5.849


  24 in total

Review 1.  Restless legs syndrome: a comprehensive overview on its epidemiology, risk factors, and treatment.

Authors:  Paul Yeh; Arthur S Walters; John W Tsuang
Journal:  Sleep Breath       Date:  2011-10-26       Impact factor: 2.816

2.  RLS in middle aged women and attention deficit/hyperactivity disorder in their offspring.

Authors:  Xiang Gao; Kristen Lyall; Natalia Palacios; Arthur S Walters; Alberto Ascherio
Journal:  Sleep Med       Date:  2011-01       Impact factor: 3.492

Review 3.  Psychiatric comorbidity in adults with attention-deficit/hyperactivity disorder (ADHD).

Authors:  Esther Sobanski
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2006-09       Impact factor: 5.270

Review 4.  Caenorhabditis elegans and its applicability to studies on restless legs syndrome.

Authors:  Pan Chen; Omamuyovwi Meashack Ijomone; Kun He Lee; Michael Aschner
Journal:  Adv Pharmacol       Date:  2019-03-14

5.  A case of compulsive behaviors observed in a restless legs syndrome patient treated with a dopamine agonist.

Authors:  Rachel E Salas; Richard P Allen; Christopher J Earley; Charlene E Gamaldo
Journal:  Sleep       Date:  2009-05       Impact factor: 5.849

6.  Iron and manganese-related CNS toxicity: mechanisms, diagnosis and treatment.

Authors:  Pan Chen; Melissa Totten; Ziyan Zhang; Hana Bucinca; Keith Erikson; Abel Santamaría; Aaron B Bowman; Michael Aschner
Journal:  Expert Rev Neurother       Date:  2019-02-21       Impact factor: 4.618

7.  L-Dopa improves Restless Legs Syndrome and periodic limb movements in sleep but not Attention-Deficit-Hyperactivity Disorder in a double-blind trial in children.

Authors:  Sandra J England; Daniel L Picchietti; Barbara Vera Couvadelli; Barbara C Fisher; Fouzia Siddiqui; Mary L Wagner; Wayne A Hening; Daniel Lewin; Glenna Winnie; Barry Cohen; Arthur S Walters
Journal:  Sleep Med       Date:  2011-04-03       Impact factor: 3.492

Review 8.  Diagnosis and management of restless legs syndrome in children.

Authors:  Narong Simakajornboon; Leila Kheirandish-Gozal; David Gozal
Journal:  Sleep Med Rev       Date:  2009-01-31       Impact factor: 11.609

Review 9.  Restless legs syndrome: pathophysiology, diagnosis and treatment.

Authors:  Pankaj Satija; William G Ondo
Journal:  CNS Drugs       Date:  2008       Impact factor: 5.749

10.  Effect of lisdexamfetamine dimesylate on sleep in adults with attention-deficit/hyperactivity disorder.

Authors:  Lenard A Adler; David Goodman; Richard Weisler; Mohamed Hamdani; Thomas Roth
Journal:  Behav Brain Funct       Date:  2009-08-03       Impact factor: 3.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.